🎯 check Quizartinib (AC220) product page
Quizartinib (AC220) is a potent, highly selective type II FLT3 inhibitor. It blocks FLT3/STAT5/AKT signaling by binding to the receptor and inhibiting its autophosphorylation, effectively suppressing cell proliferation and inducing apoptosis in acute myeloid leukemia.